Strengthening research and science leadership capacity of early- and mid-career research scientists in Africa and India.
Features
March 7, 2023
IAVI and WomenLift Health explore why investing in women’s leadership development in science is beneficial to global health research.
A new brief calls on decision-makers to prioritize tuberculosis vaccine R&D in all global health and antimicrobial resistance agendas.
February 22, 2023
The Ministry will award IAVI €21 million over the next five years as part of the Product Development Partnership IV Fund.
February 7, 2023
Three regulatory experts discuss alternative approaches for demonstrating the effectiveness of vaccines against deadly filoviruses.
January 30, 2023
New IAVI white paper identifies critical gaps across R&D, equitable access, and financing.
This EGM characterizes the evidence base of SBCC interventions for strengthening HIV prevention and research among AGYW in LMICs.
January 19, 2023
Janssen-sponsored trial discontinued due to lack of efficacy.
January 11, 2023
Reflecting on the Ebola Sudan outbreak in Uganda, Swati Gupta suggests a global solution to prepare for emerging infectious disease outbreaks.
December 21, 2022
Blog perspective from a graduate of the first cohort of the IAVI ADVANCE Leadership Development Program.
December 20, 2022
First shipment of IAVI’s Sudan virus (SUDV) vaccine candidate has arrived in Entebbe, Uganda.
Show More
Media Contacts
North America
Rose Catlos
+1 212 847 1049
RCatlos@iavi.org
